Michele Moschetta, MD PhD
Michele Moschetta, MD PhD
Clinical Program Leader at Novartis Institutes for BioMedical Research (NIBR)
Verified email at novartis.com
Cited by
Cited by
Engineered nanomedicine for myeloma and bone microenvironment targeting
A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ...
Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014
Targeting the bone marrow microenvironment in multiple myeloma
Y Kawano, M Moschetta, S Manier, S Glavey, GT Görgün, AM Roccaro, ...
Immunological reviews 263 (1), 160-172, 2015
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma
AM Roccaro, A Sacco, C Jimenez, P Maiso, M Moschetta, Y Mishima, ...
Blood, The Journal of the American Society of Hematology 123 (26), 4120-4131, 2014
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment
YT Tai, C Acharya, G An, M Moschetta, MY Zhong, X Feng, M Cea, ...
Blood 127 (25), 3225-3236, 2016
Metabolic signature identifies novel targets for drug resistance in multiple myeloma
P Maiso, D Huynh, M Moschetta, A Sacco, Y Aljawai, Y Mishima, ...
Cancer research 75 (10), 2071-2082, 2015
BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer
M Moschetta, A George, SB Kaye, S Banerjee
Annals of Oncology 27 (8), 1449-1455, 2016
SDF-1 inhibition targets the bone marrow niche for cancer therapy
AM Roccaro, A Sacco, WG Purschke, M Moschetta, K Buchner, C Maasch, ...
Cell reports 9 (1), 118-128, 2014
Therapeutic targeting of the mTOR‐signalling pathway in cancer: benefits and limitations
M Moschetta, A Reale, C Marasco, A Vacca, MR Carratù
British journal of pharmacology 171 (16), 3801-3813, 2014
Role of endothelial progenitor cells in cancer progression
M Moschetta, Y Mishima, I Sahin, S Manier, S Glavey, A Vacca, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 26-39, 2014
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation
AM Roccaro, Y Mishima, A Sacco, M Moschetta, YT Tai, J Shi, Y Zhang, ...
Cell reports 12 (4), 622-635, 2015
Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin–positive metastatic human melanoma xenografts
M Moschetta, F Pretto, A Berndt, K Galler, P Richter, A Bassi, P Oliva, ...
Cancer research 72 (7), 1814-1824, 2012
The cancer glycome: carbohydrates as mediators of metastasis
SV Glavey, D Huynh, MR Reagan, S Manier, M Moschetta, Y Kawano, ...
Blood reviews 29 (4), 269-279, 2015
The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma
SV Glavey, S Manier, A Natoni, A Sacco, M Moschetta, MR Reagan, ...
Blood, The Journal of the American Society of Hematology 124 (11), 1765-1776, 2014
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma
A De Luisi, A Ferrucci, AML Coluccia, R Ria, M Moschetta, E De Luca, ...
Clinical Cancer Research 17 (7), 1935-1946, 2011
Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma
M Moschetta, G Di Pietro, R Ria, A Gnoni, G Mangialardi, A Guarini, ...
European Journal of Cancer 46 (2), 420-429, 2010
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies
MA Frassanito, L Rao, M Moschetta, R Ria, L Di Marzo, A De Luisi, ...
Leukemia 28 (4), 904-916, 2014
Bone marrow angiogenesis and progression in multiple myeloma
R Ria, A Reale, A De Luisi, A Ferrucci, M Moschetta, A Vacca
American journal of blood research 1 (1), 76, 2011
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma
M Moschetta, A Basile, A Ferrucci, MA Frassanito, L Rao, R Ria, ...
Clinical cancer research 19 (16), 4371-4382, 2013
Pyk2 promotes tumor progression in multiple myeloma
Y Zhang, M Moschetta, D Huynh, YT Tai, Y Zhang, W Zhang, Y Mishima, ...
Blood, The Journal of the American Society of Hematology 124 (17), 2675-2686, 2014
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target
A Ferrucci, M Moschetta, MA Frassanito, S Berardi, I Catacchio, R Ria, ...
Clinical cancer research 20 (22), 5796-5807, 2014
The system can't perform the operation now. Try again later.
Articles 1–20